These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 22201551)
1. Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I? Jack MM; Ryals JM; Wright DE Exp Neurol; 2012 Mar; 234(1):62-9. PubMed ID: 22201551 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy. Jack MM; Ryals JM; Wright DE Diabetologia; 2011 Aug; 54(8):2174-82. PubMed ID: 21633909 [TBL] [Abstract][Full Text] [Related]
3. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Jack M; Wright D Transl Res; 2012 May; 159(5):355-65. PubMed ID: 22500508 [TBL] [Abstract][Full Text] [Related]
4. Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy. Noh SU; Lee WY; Kim WS; Lee YT; Yoon KJ Mol Pain; 2018; 14():1744806918775482. PubMed ID: 29690804 [TBL] [Abstract][Full Text] [Related]
5. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes. Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743 [TBL] [Abstract][Full Text] [Related]
11. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice. Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499 [TBL] [Abstract][Full Text] [Related]
12. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients. Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889 [TBL] [Abstract][Full Text] [Related]
13. Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis. Wang X; Li Q; Han X; Gong M; Yu Z; Xu B Front Endocrinol (Lausanne); 2021; 12():655591. PubMed ID: 34295304 [TBL] [Abstract][Full Text] [Related]
14. Glyoxalase 1 expression is downregulated in preimplantation blastocysts of diabetic rabbits. Seeling T; Haucke E; Navarrete Santos A; Grybel KJ; Gürke J; Pendzialek SM; Schindler M; Simm A; Navarrete Santos A Reprod Domest Anim; 2019 Sep; 54 Suppl 3():4-11. PubMed ID: 31512318 [TBL] [Abstract][Full Text] [Related]
15. Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients. Skapare E; Konrade I; Liepinsh E; Strele I; Makrecka M; Bierhaus A; Lejnieks A; Pirags V; Dambrova M J Diabetes Complications; 2013; 27(3):262-7. PubMed ID: 23351995 [TBL] [Abstract][Full Text] [Related]
16. Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells. Morgenstern J; Fleming T; Schumacher D; Eckstein V; Freichel M; Herzig S; Nawroth P J Biol Chem; 2017 Feb; 292(8):3224-3238. PubMed ID: 27956549 [TBL] [Abstract][Full Text] [Related]
17. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. Rojas DR; Kuner R; Agarwal N J Mol Med (Berl); 2019 Jun; 97(6):845-854. PubMed ID: 30949723 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice. Giacco F; Du X; D'Agati VD; Milne R; Sui G; Geoffrion M; Brownlee M Diabetes; 2014 Jan; 63(1):291-9. PubMed ID: 24062246 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species. Rojas DR; Tegeder I; Kuner R; Agarwal N J Mol Med (Berl); 2018 Dec; 96(12):1395-1405. PubMed ID: 30361814 [TBL] [Abstract][Full Text] [Related]
20. Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction. Blackburn NJR; Vulesevic B; McNeill B; Cimenci CE; Ahmadi A; Gonzalez-Gomez M; Ostojic A; Zhong Z; Brownlee M; Beisswenger PJ; Milne RW; Suuronen EJ Basic Res Cardiol; 2017 Sep; 112(5):57. PubMed ID: 28864889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]